Pharmacy

Below are 10 of the top pharmacy stories published by Becker's Hospital Review in October, beginning with the most popular:

Biogen and Alkermes won approval Oct. 30 for their new multiple sclerosis drug, Vumerity, according to The Boston Globe.

Walgreens and CareSource, Ohio's largest Medicaid provider, are no longer working together, leaving half of Ohio's Medicaid recipients without access to Walgreens pharmacies, according to The Columbus Dispatch. Walgreens is Ohio's second-largest pharmacy retailer, which means parts of Ohio could…

Walgreens' decision to close its wholly-owned health clinics could serve as a warning to other retailers looking to start their own clinics, according to The Motley Fool. 

Michigan's Senate voted Oct. 30 to reject a state regulatory commission's recommendation to regulate and limit the number of hospitals that can administer CAR-T cell therapy, according to Crain's Detroit Business.

Six of the world's largest drugmakers reported third quarter earnings that exceeded Wall Street's expectations, according to BioPharma Dive. 

CVS Pharmacy opened its first standalone store in Oregon on Oct. 29.

A bipartisan Senate bill designed to stop drug companies from manipulating the patent system to block cheaper competitors from the market has been stalled in the debate over drug prices, according to Politico.

An FDA advisory panel recommended the agency remove Makena, a treatment for preventing preterm births, from the market after reviewing data that shows it may not be effective, according to STAT. 

Walgreens Boots Alliance plans to develop more than 30 "small store" pharmacies, mostly in big cities, that will focus less on retail and more on health and wellness, according to Forbes.